Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Merus N.V. CS (NQ: MRUS )

18.53 +4.55 (+32.55%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 27, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 675,952
Open 14.50
Bid (Size) 18.78 (1)
Ask (Size) 19.45 (4)
Prev. Close 13.98
Today's Range 14.50 - 18.72
52wk Range 13.46 - 33.09
Shares Outstanding 43,550,059
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
7 Top-Rated Biotech Stocks to Buy for Q2
In these tumultous economic times, look to sectors that are outside the turmoil. Each of these seven biotech stocks fit the bill. 
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For February 10, 2022
Upgrades According to Gordon Haskett, the prior rating for Williams-Sonoma Inc (NYSE:WSM) was changed from Hold to Accumulate. Williams-Sonoma earned $3.32 in the third quarter,... 
Via Benzinga

Performance

YTD
-40.05%
-40.05%
1 Month
-13.49%
-13.49%
3 Month
-34.03%
-34.03%
6 Month
-25.82%
-25.82%
1 Year
-12.39%
-12.39%

More News

Read More
Incyte Pulls Parsaclisib US Application For Lymphoma Treatment, Bows Out Solid Tumor Program With Merus
Via Benzinga
Promising Developments in Breast Cancer Treatments Ahead in 2022
Via FinancialNewsMedia
Merus Shares Updated Data From Zeno Triplet Combo Data In Breast Cancer Settings
Via Benzinga
The Daily Biotech Pulse: NRx's Zyesami Face Regulatory Rejection, Puma Slumps On Q3 Miss, Pfizer Has Good Tidings On Oral Antiviral COVID-19 Pill
Via Benzinga
Exposures COVID-19 Product Safety
The Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More
Via Benzinga
Exposures Product Safety
Notable Merus Insider Makes $31M Sale
Via Benzinga
Topics Regulatory Compliance
Exposures Legal Regulatory
The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology
Via Benzinga
Exposures COVID-19
45 Biggest Movers From Yesterday
Via Benzinga
Mid-Afternoon Market Update: Crude Oil Rises 1%; New Fortress Energy Shares Spike Higher
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
Merus Stock Flirts With Breakout After Experimental Drug Shrinks All Tumors
Via Investor's Business Daily
Mid-Day Market Update: Dow Jumps Over 500 Points; Osmotica Pharmaceuticals Shares Slide
Via Benzinga
Topics Stocks
Exposures US Equities
Here's Why Merus Stock Is Flying Higher Today
Via The Motley Fool
Why Are Merus Shares Soaring Thursday?
Via Benzinga
Mid-Morning Market Update: Markets Open Higher; Conagra Brands Profit Beats Views
Via Benzinga
Topics Stocks
Exposures US Equities
Marinus Files US Application For Ganaxolone For Genetic Epilepsy, Inks European Commercialization Pact With Orion
Via Benzinga
Exposures Product Safety
58 Biggest Movers From Yesterday
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 7, 2021
Via Benzinga
10 Biggest Price Target Changes For Monday
Via Benzinga
Merus Reveals New Data From Zeno Program in NRG1 Fusion Cancers
Via Benzinga
The Week Ahead In Biotech: ASCO Presentations Front And Center, FDA Decisions Due For Scynexis, Liminal And Alkermes
Via Benzinga
Exposures Product Safety
60 Biggest Movers From Yesterday
Via Benzinga
38 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 8, 2021
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.